Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Pfizer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
Revolution Medicines, Inc.
Second Life Therapeutics
Novartis
Revolution Medicines, Inc.
Pfizer
Metanoic Health Ltd.
Purdue University
Hoffmann-La Roche
University of Sunderland
Thomas Jefferson University